跳至主要内容
临床试验/NCT03253302
NCT03253302Unknown不适用

Laparoscopic Assisted transAnal Total Mesorectal Excision for Rectal cAncer in Low Site :A Prospective,Multi-center, Patients Registry Trial in China (LATERAL Trial)

Beijing Friendship Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年10月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
Positive rate of circumferential resection margin (CRM) of the specimens

研究概览

简要总结

At present, surgical resection is still the main treatment for the potential cure of rectal cancer. Total mesorectal excision (TME) is the gold standard. The traditional laparoscopic or open surgery for some special patients is really difficult, especially for male, prostate hypertrophy, obesity, low tumor and pelvic stenosis patients to expose the gap around the mesorectum and separate to the pelvic floor. While transanal total mesorectal excision (TaTME) approach could be more directly separate the low mesorectum and relatively simple to complete distal rectal transection, which would bring some considerable advantages. Although active learning from abroad, laparoscopic assisted TaTME surgery is now in its infancy in China. It is urgent for clinical studies to obtain the results in China. This multicenter, observational study will help to encourage research in this field and to obtain data on the safety and efficacy of this procedure in Chinese patients with rectal cancer.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adenocarcinoma of the rectum by biopsy
  • the lower edge of the tumor from the anal margin less than 10cm according to MRI or rigid endoscopy
  • tumor diameter less than 4cm
  • baseline clinical stage I-III: cT1-3 N0-2 M0 (AJCC v7)
  • tolerable to surgery
  • be able to understand and willing to participate in this trial with signature

排除标准

  • history of malignant colorectal neoplasia
  • recent diagnosis with other malignancies
  • patients requiring emergency surgery such as obstruction,perforation and bleeding
  • tumor involving adjacent organs, anal sphincter, or levator ani muscle
  • muti-focal colorectal cancer
  • preoperative poor anal function, anal stenosis, anal injury, or fecal incontinence
  • history of inflammatory bowel disease or familial adenomatous polyposis
  • participating in other clinical trails
  • can not tolerate the surgery
  • history of serious mental illness
  • pregnancy or lactating women
  • preoperative uncontrolled infection
  • the researchers believe the patients should not enrolled in

结局指标

主要结局

Positive rate of circumferential resection margin (CRM) of the specimens

时间窗: 10 days after surgery

Circumferential resection margin (CRM) is the distance between the deepest point of tumor in the primary cancer and the margin of resection in the retroperitoneum or mesentery by pathological examination. CRM 0-1mm is defined as positive, while \>1mm is negative.

次要结局

  • the operative time(30 days after surgery)
  • the rate of postoperative complications(30 days after surgery)
  • The grade score of the specimens integrity(10 days after surgery)
  • the score of postoperative life(6 months after surgery)
  • The distance between lower tumor margin and the lower reaction margin(10 days after surgery)
  • local recurrence rate(3 years after surgery)
  • postoperative hospital stay(3 year after surgery)
  • overall survival rate(3-year after surgery)
  • disease free survival rate(3-year after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhongtao Zhang

assistant dean, professor

Beijing Friendship Hospital

研究点 (1)

Loading locations...

相似试验